Olodanrigan (S)-5-(苄氧基)-2-(2,2-二苯乙酰基)-6-甲氧基-1,2,3,4-四氢异喹啉-3-羧酸
CAS 1316755-16-4 MFCD416755164
化学结构图
SMILES:
别名和识别编码
| Chemical Name Translation | (S)-5-(苄氧基)-2-(2,2-二苯乙酰基)-6-甲氧基-1,2,3,4-四氢异喹啉-3-羧酸 |
|---|---|
| Chemical Name | Olodanrigan |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
相关文献及参考
- [2]. Suguru Koyama,et al. An Electroencephalography Bioassay for Preclinical Testing of Analgesic Efficacy.
- [3]. Anand U et al. Mechanisms underlying clinical efficacy of Angiotensin II type 2 receptor (AT2R) antagonist EMA401 in neuropathic pain: clinical tissue and in vitro studies. Mol Pain. 2015 Jun 26;11:38.
- [4]. Rice AS et al. EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial.
- Lancet. 2014 May 10;383(9929):1637-47.
- Lancet. 2014 May 10;383(9929):1637-47.
- [1]. Rice AS et al. EMA401, an orally administered highly selective angiotensin II ty
- [1]. Rice AS et al. EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial.
